Cognitive resilience in Alzheimer's disease: Mechanism and potential clinical intervention

被引:0
|
作者
Jia, Bin [1 ,2 ]
Xu, Yun [1 ,3 ,4 ,5 ,6 ]
Zhu, Xiaolei [1 ,3 ,4 ,5 ,6 ]
机构
[1] Jiangsu Univ, Nanjing Drum Tower Hosp, Sch Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Jiangsu Univ, Affiliated Hosp 4, Dept Neurol, Zhenjiang, Jiangsu, Peoples R China
[3] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Peoples R China
[4] Nanjing Univ, Inst Translat Med Brain Crit Dis, Nanjing, Peoples R China
[5] Nanjing Neurol Clin Med Ctr, Nanjing, Peoples R China
[6] Nanjing Drum Tower Hosp, Brain Dis & Brain Sci Ctr, Nanjing, Peoples R China
关键词
Alzheimer's disease; Pathology; Resilience; Diagnosis; Personalized intervention strategies; TRANSCRANIAL MAGNETIC STIMULATION; AMYLOID PRECURSOR PROTEIN; DENDRITIC SPINES; PHYSICAL-ACTIVITY; OLDER-ADULTS; BETA; DEMENTIA; EXERCISE; MEMORY; NEUROPATHOLOGY;
D O I
10.1016/j.arr.2025.102711
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a globally recognized neurodegenerative disorder that severely impairs cognitive function and imposes substantial psychological and financial burdens on patients and their families. The hallmark pathological features of AD include progressive neurodegeneration, extracellular beta-amyloid (A(3) plaque accumulation, and intracellular hyperphosphorylated tau protein tangles. However, recent studies have identified a subset of patients exhibiting cognitive resilience, characterized by a slower cognitive decline or the preservation of high cognitive function despite the presence of AD pathology. Cognitive resilience is influenced by a complex interplay of genetic, environmental, and lifestyle factors. In addition, cognitive resilience contributes to the new perspectives on the diagnosis and personalized treatment of AD. This review aims to provide a comprehensive analysis of current studies on cognitive resilience in AD and to explore future research directions of AD diagnosis and treatment.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Novel approaches to increase synaptic resilience as potential treatments for Alzheimer's disease
    Pham, Andrew Q.
    Dore, Kim
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2023, 139 : 84 - 92
  • [32] Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment
    Ke, Jia
    Tian, Qinfang
    Xu, Qixia
    Fu, Zhenqin
    Fu, Qiang
    DRUG DISCOVERY TODAY, 2021, 26 (08) : 1991 - 2002
  • [33] Cognitive functions blocked in Alzheimer's disease, an epigenetic mechanism revealed?
    Rei, Damien
    M S-MEDECINE SCIENCES, 2012, 28 (12): : 1060 - 1063
  • [34] Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline?
    Hancock, Sara M.
    Finkelstein, David I.
    Adlard, Paul A.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [35] Lou/c/jall rats as a model of cognitive resilience in the field of Alzheimer's disease
    Leger, M.
    Haelewyn, B.
    Freret, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S736 - S736
  • [36] Neural correlates of cognitive intervention in persons at risk of developing Alzheimer's disease
    Hosseini, S. M. Hadi
    Kramer, Joel H.
    Kesler, Shelli R.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [37] Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits
    Katariya, Raj A.
    Sammeta, Shivkumar S.
    Kale, Mayur B.
    Kotagale, Nandkishor R.
    Umekar, Milind J.
    Taksande, Brijesh G.
    AGEING RESEARCH REVIEWS, 2024, 96
  • [38] The Potential for Psychedelics to Improve Coping Skills and Resilience in Persons With Newly Diagnosed Mild Cognitive Impairment or Early Alzheimer's Disease
    Steinberg, Martin
    Rosenberg, Paul
    Garcia-Romeu, Albert
    CURRENT GERIATRICS REPORTS, 2023, 12 (03) : 149 - 155
  • [39] The Potential for Psychedelics to Improve Coping Skills and Resilience in Persons With Newly Diagnosed Mild Cognitive Impairment or Early Alzheimer’s Disease
    Martin Steinberg
    Paul Rosenberg
    Albert Garcia-Romeu
    Current Geriatrics Reports, 2023, 12 : 149 - 155
  • [40] Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease
    Xi, Meiyang
    Sun, Tianyu
    Chai, Shejie
    Xie, Mengjiao
    Chen, Siqi
    Deng, Liping
    Du, Kui
    Shen, Runpu
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232